Mivacurium is a short acting non-depolarising neuromuscular blocking agent.
Short duration of action is due to a rapid hydrolysis by plasma cholineste
rase (CHe). The duration of neuromuscular blockade can be prolonged by an a
bnormal variant of CHe. We report a case of a newborn with neuromuscular bl
ockade for a duration of 8 hours following mivacurium 0.2 mg.kg(-1), CHe ac
tivity values were not contributive for the diagnosis. The diagnosis was ob
tained with molecular study showing the new-born homozygocity. The whole fa
mily was heterozygous. This case emphasises the lack of precision of CHe ac
tivity measurement during the first 6 months of life. (C) 1998 Elsevier, Pa
ris.